|
|
||||||||
Ann Thorac Surg 1998;66:1469
© 1998 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, St. Lukes Hospital, GMangia, Malta
b Department of Paediatrics, University of Sheffield, Sheffield, United Kingdom
e-mail: josegale{at}orbit.net.mt
To the Editor
In the March 1998 issue of The Annals of Thoracic Surgery, Boldt and colleagues demonstrated [1] that levels of circulating adhesion molecules increase significantly after coronary artery bypass grafting but not after pneumonectomy or Whipples pancreaticoduodenectomy.
In a similar study [2], we found the same trend with some differences. In 7 patients undergoing uncomplicated coronary artery bypass grafting we studied circulating intercellular adhesion molecule-1 (ICAM-1) and soluble E-selectin levels throughout cardiopulmonary bypass (CPB) and up to 48 hours after the operation. We measured plasma levels of these soluble adhesion molecules at eight time points: before the institution of, during, and at the end of CPB and at 1, 2, 3, 24, and 48 hours after the operation. Boldt and colleagues did not study the plasma levels during their prolonged surgical procedure and consequently did not report on circulating adhesion molecule behavior during CPB. We showed that the plasma levels of ICAM-1 and E-selectin decrease significantly during CPB even when corrected for hemodilution. Subsequently the levels of circulating ICAM-1 and E-selectin did not rise as high nor as early as those described in the study by Boldt and associates, circulating ICAM-1 levels reaching a statistically significant increase compared with the pre-CPB level at 24 hours after operation and soluble E-selectin levels never reaching a statistically significant increase. These differences may be the result of a more intense endothelial injury in the study reported in The Annals, in which CPB times were significantly longer (101.8 ± 14.4 minutes compared with 73.9 ± 4 minutes in our study). Normothermic bypass (33° to 37°C) has been shown to be associated with increased plasma levels of circulating ICAM-1 compared with hypothermic bypass (28° to 30°C) [3]. The core temperature was kept greater than 35°C in the study by Boldt and associates, whereas our patients were maintained at 32°C during CPB.
In conclusion, our study highlights the benefits of shorter CPB at 32°C as evidenced by a lesser rise in levels of circulating adhesion molecules.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |